Login


TI Ref No : 528588157
Description : Conclusion Of Non-exclusive Agreements For Medicines Containing The Active Ingredient Fremanezumab (atc Code: N02cd03) Through An Open-house Model
Date : 2026-02-07
Deadline : 2026-08-05
Document Type : Tenders
View Details
Whats app